Compare Novartis with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ELDER PHARMA - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS ELDER PHARMA NOVARTIS/
ELDER PHARMA
 
P/E (TTM) x 2,073.7 -0.2 - View Chart
P/BV x 27.5 0.1 27,279.7% View Chart
Dividend Yield % 1.6 0.0 -  

Financials

 NOVARTIS   ELDER PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-19
ELDER PHARMA
Jun-14
NOVARTIS/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs980380 257.9%   
Low Rs600188 319.3%   
Sales per share (Unadj.) Rs198.7491.2 40.5%  
Earnings per share (Unadj.) Rs21.0-3.2 -659.0%  
Cash flow per share (Unadj.) Rs22.314.4 154.5%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.5376.5 81.7%  
Shares outstanding (eoy) m24.6920.54 120.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.00.6 687.6%   
Avg P/E ratio x37.7-89.3 -42.2%  
P/CF ratio (eoy) x35.519.7 180.1%  
Price / Book Value ratio x2.60.8 340.7%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,5085,833 334.4%   
No. of employees `0000.6NA-   
Total wages/salary Rs m1,1712,179 53.7%   
Avg. sales/employee Rs Th8,445.4NM-  
Avg. wages/employee Rs Th2,015.7NM-  
Avg. net profit/employee Rs Th891.0NM-  
INCOME DATA
Net Sales Rs m4,90710,089 48.6%  
Other income Rs m783257 305.0%   
Total revenues Rs m5,68910,346 55.0%   
Gross profit Rs m123-792 -15.5%  
Depreciation Rs m32361 8.8%   
Interest Rs m162,756 0.6%   
Profit before tax Rs m858-3,653 -23.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m340125 271.7%   
Profit after tax Rs m518-65 -792.2%  
Gross profit margin %2.5-7.8 -31.9%  
Effective tax rate %39.6-3.4 -1,157.0%   
Net profit margin %10.6-0.6 -1,628.9%  
BALANCE SHEET DATA
Current assets Rs m8,0559,240 87.2%   
Current liabilities Rs m1,8509,998 18.5%   
Net working cap to sales %126.4-7.5 -1,683.7%  
Current ratio x4.40.9 471.1%  
Inventory Days Days4546 97.2%  
Debtors Days Days3460 56.6%  
Net fixed assets Rs m15010,124 1.5%   
Share capital Rs m123206 60.0%   
"Free" reserves Rs m7,4695,582 133.8%   
Net worth Rs m7,5927,734 98.2%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m9,82422,882 42.9%  
Interest coverage x54.9-0.3 -16,890.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.50.4 113.3%   
Return on assets %5.411.8 46.2%  
Return on equity %6.8-0.8 -807.0%  
Return on capital %11.522.3 51.6%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m58307 18.8%   
Fx outflow Rs m1,326125 1,058.5%   
Net fx Rs m-1,269181 -699.8%   
CASH FLOW
From Operations Rs m-1,94311,754 -16.5%  
From Investments Rs m2,742-561 -489.3%  
From Financial Activity Rs m-298-6,762 4.4%  
Net Cashflow Rs m5014,432 11.3%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 7.5 26.7%  
FIIs % 1.6 16.8 9.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 36.1 59.6%  
Shareholders   41,647 16,479 252.7%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  IPCA LABS  NATCO PHARMA  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Feb 26, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS